Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma, Mucosal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT02519322
What this trial is testing

Neoadjuvant and Adjuvant Checkpoint Blockade

Who this might be right for
Cutaneous MelanomaMucosal MelanomaOcular Melanoma+8 more
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Looking for participantsNCT06797297
What this trial is testing

Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy

Who this might be right for
Melanoma
Innovent Biologics (Suzhou) Co. Ltd. 180
Testing effectiveness (Phase 2)UnknownNCT04472806
What this trial is testing

Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
Fudan University 31
Testing effectiveness (Phase 2)Study completedNCT01827111
What this trial is testing

Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04622566
What this trial is testing

Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma

Who this might be right for
Mucosal MelanomaNeoadjuvant Treatment
Peking University Cancer Hospital & Institute 26
Not applicableStudy completedNCT03319693
What this trial is testing

Molecular Characterization of Primary Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
CHU de Reims 65
Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680
What this trial is testing

Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00881049
What this trial is testing

Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Peking University 1
Not applicableLooking for participantsNCT06952400
What this trial is testing

The Registry Study of Genetic Alterations of Melanoma in Taiwan

Who this might be right for
Primary Melanoma of the Extremity
National Health Research Institutes, Taiwan 250
Not applicableStudy completedNCT07506447
What this trial is testing

The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma

Who this might be right for
FDG PETMucosal Melanoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 68
Testing effectiveness (Phase 2)Looking for participantsNCT04511013
What this trial is testing

Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Who this might be right for
Acral Lentiginous MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+4 more
SWOG Cancer Research Network 112
Testing effectiveness (Phase 2)UnknownNCT03986515
What this trial is testing

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Who this might be right for
Mucosal MelanomaAdvanced CancerApatinib+1 more
Henan Cancer Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01119508
What this trial is testing

Ipilimumab + Temozolomide in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
M.D. Anderson Cancer Center 64
Early research (Phase 1)Ended earlyNCT05341349
What this trial is testing

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Melanoma of Unknown PrimaryMetastatic Malignant Neoplasm in the Brain+4 more
Emory University 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07347444
What this trial is testing

Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma

Who this might be right for
Acral MelanomaMucosal Melanoma
Fudan University 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236528
What this trial is testing

Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Early research (Phase 1)Ended earlyNCT07076550
What this trial is testing

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

Who this might be right for
Melanoma MetastaticUveal Melanoma, MetastaticMucosal Melanoma
Alpha-9 Oncology USA Inc. 5
Next Page